Showing results (2201-2210 of 3,237) with videos related to
Sort By:
Pageof 324
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
DNA-topoisomerase I, a new target for the treatment of neuroblastomaG Vassal, C Pondarré, C Cappelli, et al.Molecules (Basel, Switzerland)|May 5, 2019
Small AntiMicrobial Peptide With in Vivo Activity Against SepsisHéloise Boullet, Fayçal Bentot, Arnaud Hequet, et al.American Journal of Medical Genetics|January 25, 2002
Osteopathia striata cranial sclerosis: non-random X-inactivation suggestive of X-linked dominant inheritanceGéraldine Viot, Didier Lacombe, Albert David, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|September 14, 2011
Imatinib-ULS-lysozyme: a proximal tubular cell-targeted conjugate of imatinib for the treatment of renal diseasesM E M Dolman, K M A van Dorenmalen, E H E Pieters, et al.The Journal of Sexual Medicine|August 13, 2011
Women's bike seats: a pressing matter for competitive female cyclistsMarsha K Guess, Sarah N Partin, Steven Schrader, et al.Cancer Epidemiology|August 20, 2011
Investigating the completeness of a histopathological cancer registry: estimation by capture-recapture analysis in a French geographical unit Alpes-Maritimes, 2008Laurent Bailly, Bernard Giusiano, Eugènia Mariné Barjoan, et al.British Journal of Cancer|July 2, 1999
Assessment of bone response to systemic therapy in an EORTC trial: preliminary experience with the use of collagen cross-link excretion. European Organization for Research and Treatment of CancerJ Vinholes, R Coleman, D Lacombe, et al.AIDS (London, England)|November 21, 2007
Impact of chronic hepatitis C and/or D on liver fibrosis severity in patients co-infected with HIV and hepatitis B virusKarine Lacombe, Anders Boyd, Moise Desvarieux, et al.Vaccine|June 23, 2010
Cross-clade immunity in cats vaccinated with a canarypox-vectored avian influenza vaccineKoert J Stittelaar, Valérie Lacombe, Rob van Lavieren, et al.Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|November 19, 2008
Sustained increase of HDL cholesterol over a 72-week period in HIV-infected patients exposed to an antiretroviral regimen including lopinavir/ritonavirJean-Luc Meynard, Karine Lacombe, Jean-Marie Poirier, et al.Pageof 324